Us Congress 2023-2024 Regular Session

Us Congress House Bill HB2666

Introduced
4/18/23  
Refer
4/18/23  
Refer
5/15/23  

Caption

Medicaid VBPs for Patients Act

Impact

If passed, HB2666 would necessitate significant changes to how Medicaid operates in terms of drug procurement and pricing. It would introduce guidelines for implementing value-based purchasing arrangements, allowing states to negotiate prices contingent upon defined patient health outcomes. This move is anticipated to foster innovation in drug development, pressuring manufacturers to optimize their products for better patient outcomes, while simultaneously aiming to reduce the overall state expenditure on Medicaid drugs.

Summary

House Bill 2666, known as the Medicaid VBPs for Patients Act, aims to amend Title XIX of the Social Security Act by codifying value-based purchasing arrangements under the Medicaid program. This legislation seeks to enhance patient access to drugs while potentially lowering costs through negotiated pricing structures that align payments with patient outcomes. The intention is to create a more efficient healthcare delivery system that prioritizes effective treatments and encourages pharmaceuticals manufacturers to provide affordable drug options based on their therapeutic value.

Sentiment

Discussions surrounding HB2666 display a generally supportive sentiment among advocates for innovation in healthcare and cost management. Proponents argue that the bill can fundamentally enhance the way value is assessed in drug pricing, potentially yielding better health outcomes. However, concerns have emerged regarding its implementation and the management of these purchasing arrangements, with skeptics warning that without robust oversight, the bill could lead to unintended consequences in patient care and access to medications.

Contention

The notable points of contention include the potential effects on drug accessibility for vulnerable populations. Critics are worried that tying drug prices to patient outcomes may unintentionally disadvantage those who are harder to treat or may not achieve specified health metrics. Furthermore, the balance between incentivizing pharmaceutical companies and protecting patient rights under Medicaid has emerged as a sensitive issue, raising questions about equity in healthcare provision.

Companion Bills

No companion bills found.

Previously Filed As

US SB4204

MVP Act Medicaid VBPs for Patients Act

US HB1433

Kids' Access to Primary Care Act of 2025This bill modifies payments for Medicaid primary care services. Specifically, the bill applies a Medicare payment rate floor to Medicaid primary care services that are provided after the date of enactment of the bill and extends the payment rate to additional types of practitioners (e.g., obstetricians).The Centers for Medicare & Medicaid Services must conduct a study on the number of children enrolled in Medicaid, the number of providers receiving payment for primary care services, and associated payment rates before and after the bill's implementation.

US HB8261

Preserving Telehealth, Hospital, and Ambulance Access Act

US HB10058

Medicaid Breast Cancer Access to Treatment Act

US HB8811

America’s Conservation Enhancement Reauthorization Act of 2024

US HB608

Cover Outstanding Vulnerable Expansion-eligible Residents Now Act or the COVER Now Act This bill establishes a demonstration program to allow local governments to provide health benefits to the Medicaid expansion population in states that have not expanded Medicaid. Under the program, local governments may provide coverage for individuals who are newly eligible for Medicaid under the Patient Protection and Affordable Care Act (i.e., the Medicaid expansion population) for a maximum of 10 years, or until their respective states expand Medicaid. The bill provides a 100% federal matching rate for the first three years of program participation. The bill prohibits states from taking certain actions against participating localities, such as withholding funding, increasing taxes, or restricting provider participation. States that violate these requirements are subject to certain funding penalties.

US HB10006

CAT Act of 2024 Centers for Medicare & Medicaid Services Auditor Transparency Act of 2024

US HB3230

Unfunded Mandates Accountability and Transparency Act of 2023

US HB10317

To amend title XIX of the Social Security Act to establish a community engagement requirement for certain individuals under the Medicaid program.

US HB2666

CBO Scoring Accountability Act

Similar Bills

US HB2491

ABC Act Alleviating Barriers for Caregivers Act

US SB3882

Helping States Integrate Medicare and Medicaid Act

US SB4063

State Public Option Act

US HB1510

Due Process Continuity of Care Act

US SB1720

Due Process Continuity of Care Act

US HB8503

DUALS Act of 2024 Delivering Unified Access to Lifesaving Services Act of 2024

US SB4122

Continuous Skilled Nursing Quality Improvement Act of 2024

US HB1433

Kids' Access to Primary Care Act of 2025This bill modifies payments for Medicaid primary care services. Specifically, the bill applies a Medicare payment rate floor to Medicaid primary care services that are provided after the date of enactment of the bill and extends the payment rate to additional types of practitioners (e.g., obstetricians).The Centers for Medicare & Medicaid Services must conduct a study on the number of children enrolled in Medicaid, the number of providers receiving payment for primary care services, and associated payment rates before and after the bill's implementation.